Abzena and BioXpress Collaborate to Develop and Manufacture Biosimilars for Third Party Customers

Shots:

• The alliance creates an integrated solution between the companies with expertise in biosimilar development and GMP manufacture
• The collaboration will benefit biosimilar drug developers with the design consultancy, cell line and process development through to clinical and commercial GMP manufacture
• The partnership provides a flexible & innovative approach from small scale biosimilar development through to large scale manufacturing

Click here to read full press release/ article | Ref: Abzena | Image: Business Wire